Semnur Pharmaceuticals, Inc. Increase (Decrease) in Due to Related Parties
Semnur Pharmaceuticals, Inc. (SMNR) reported Increase (Decrease) in Due to Related Parties of $35.68 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2025-06-30 was $18.47K, a 40.08% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2025-03-31 was $17.21K, a 50.56% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2024-12-31 was $16.71K, a 116.16% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2024-09-30 was $15.21K, a 160.33% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2024 was $56.53K, a 213.71% increase from fiscal 2023.
- Semnur Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2023 was $18.02K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2025-06-30 | $18.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $35.68K 10-Q · filed 2025-08-15 | $52.39K derived: sum of 3 quarters · filed 2025-08-15 | $67.60K derived: sum of 4 quarters · filed 2025-08-15 |
| 2025-03-31 | $17.21K 10-Q · filed 2025-05-16 | $33.92K derived: sum of 2 quarters · filed 2025-05-16 | $49.13K derived: sum of 3 quarters · filed 2025-05-16 | $62.31K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-12-31 | $16.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $31.92K derived: sum of 2 quarters · filed 2025-04-02 | $45.10K derived: sum of 3 quarters · filed 2025-08-15 | $56.53K 10-K · filed 2025-04-02 |
| 2024-09-30 | $15.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $28.39K derived: sum of 2 quarters · filed 2025-08-15 | $39.82K 10-Q · filed 2024-11-19 | $47.55K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-06-30 | $13.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $24.62K 10-Q · filed 2025-08-15 | $32.35K derived: sum of 3 quarters · filed 2025-08-15 | $38.19K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | $11.43K 10-Q · filed 2025-05-16 | $19.16K derived: sum of 2 quarters · filed 2025-05-16 | $25.00K derived: sum of 3 quarters · filed 2025-05-16 | |
| 2023-12-31 | $7.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $13.57K derived: sum of 2 quarters · filed 2025-04-02 | $18.02K 10-K · filed 2025-04-02 | |
| 2023-09-30 | $5.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $10.29K 10-Q · filed 2024-11-19 | ||
| 2023-06-30 | $4.45K 10-Q · filed 2024-08-19 |